ESR1 and cancer: The overlapping targets—AR, ESR1, HIF1A, MAPK1, NFE2L2, PTGS2, TNF, TP53, and GMNN—are crucial for reproductive health, immune response, inflammation, and cancer prevention (Figure S1A).